SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-24-000131
Filing Date
2024-04-24
Accepted
2024-04-24 13:27:50
Documents
53
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rgbp033124form10q.htm   iXBRL 10-Q 1090979
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 9481
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 9481
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 4221
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 4098
  Complete submission text file 0001607062-24-000131.txt   3841080

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE rgbp-20240331.xsd EX-101.SCH 41882
7 XBRL CALCULATION FILE rgbp-20240331_cal.xml EX-101.CAL 44200
8 XBRL DEFINITION FILE rgbp-20240331_def.xml EX-101.DEF 113380
9 XBRL LABEL FILE rgbp-20240331_lab.xml EX-101.LAB 216110
10 XBRL PRESENTATION FILE rgbp-20240331_pre.xml EX-101.PRE 191285
56 EXTRACTED XBRL INSTANCE DOCUMENT rgbp033124form10q_htm.xml XML 464310
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-722-5505
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 333-191725 | Film No.: 24869446
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)